{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:57:22Z","timestamp":1775267842312,"version":"3.50.1"},"reference-count":147,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/pap.0b013e3181a9d5d2","type":"journal-article","created":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T07:26:35Z","timestamp":1245309995000},"page":"216-235","source":"Crossref","is-referenced-by-count":14,"title":["Diffuse Aggressive B-cell Lymphomas"],"prefix":"10.1097","volume":"16","author":[{"given":"Jonathan","family":"Said","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1038\/sj.onc.1210376","article-title":"Rituximab therapy in malignant lymphoma","volume":"26","author":"Coiffier","year":"2007","journal-title":"Oncogene"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/00001813-200211002-00007","article-title":"Aggressive lymphoma: improving treatment outcome with rituximab","volume":"13","author":"Coiffier","year":"2002","journal-title":"Anticancer Drugs"},{"key":"R4-4-20210202","article-title":"The Epstein-Barr Virus and Associated Diseases","author":"Hummel","year":"1993"},{"key":"R5-4-20210202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/path.1711750303","article-title":"Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types","volume":"175","author":"Hummel","year":"1995","journal-title":"J Pathol"},{"key":"R6-4-20210202","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2007-01-067769","article-title":"The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma","volume":"110","author":"Park","year":"2007","journal-title":"Blood"},{"key":"R7-4-20210202","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"R8-4-20210202","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2559.1990.tb00709.x","article-title":"CD30 expression in non-Hodgkin's lymphoma","volume":"17","author":"Piris","year":"1990","journal-title":"Histopathology"},{"key":"R9-4-20210202","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/path.1485","article-title":"Differential Emu enhancer activity and expression of BOB.1\/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas","volume":"202","author":"Loddenkemper","year":"2004","journal-title":"J Pathol"},{"key":"R10-4-20210202","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood-2004-03-1209","article-title":"Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome","volume":"104","author":"Barrans","year":"2004","journal-title":"Blood"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/42CQ0HU7XEY9QMQX","article-title":"A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus","volume":"129","author":"Ehinger","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R12-4-20210202","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.leukres.2006.11.004","article-title":"Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients","volume":"31","author":"Niitsu","year":"2007","journal-title":"Leuk Res"},{"key":"R13-4-20210202","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<281::AID-PATH1134>3.0.CO;2-Z","article-title":"Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas","volume":"183","author":"Pescarmona","year":"1997","journal-title":"J Pathol"},{"issue":"3","key":"R15-4-20210202","first-page":"318","article-title":"Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms","volume":"11","author":"Muramatsu","year":"1997","journal-title":"Leukemia"},{"key":"R16-4-20210202","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood.V99.7.2285","article-title":"The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile","volume":"99","author":"Huang","year":"2002","journal-title":"Blood"},{"key":"R17-4-20210202","first-page":"161","article-title":"Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma\u2014A Nordic Lymphoma Group Study","volume":"20","author":"Jerkeman","year":"2002","journal-title":"Int J Oncol"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/01.pas.0000182405.65041.8b","article-title":"Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens","volume":"29","author":"Arber","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0609.2006.00644.x","article-title":"The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement","volume":"76","author":"Campbell","year":"2006","journal-title":"Eur J Haematol"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/ajcp\/101.3.305","article-title":"Bone marrow involvement in large-cell lymphoma. Prognostic implications of discordant disease","volume":"101","author":"Hodges","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood-2007-01-070300","article-title":"Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index","volume":"110","author":"Chung","year":"2007","journal-title":"Blood"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.LAB.0000050762.61660.27","article-title":"Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders","volume":"83","author":"Kremer","year":"2003","journal-title":"Lab Invest"},{"key":"R23-4-20210202","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1200\/JCO.1991.9.2.236","article-title":"Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse","volume":"9","author":"Robertson","year":"1991","journal-title":"J Clin Oncol"},{"key":"R24-4-20210202","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/00313020701684417","article-title":"Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study","volume":"39","author":"Talaulikar","year":"2007","journal-title":"Pathology"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1200\/JCO.2005.15.503","article-title":"Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas","volume":"23","author":"De Paepe","year":"2005","journal-title":"J Clin Oncol"},{"key":"R26-4-20210202","first-page":"2291","article-title":"Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor","volume":"89","author":"Engelhard","year":"1997","journal-title":"Blood"},{"key":"R27-4-20210202","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1365-2141.2000.02045.x","article-title":"Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas","volume":"109","author":"Haralambieva","year":"2000","journal-title":"Br J Haematol"},{"key":"R28-4-20210202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"R29-4-20210202","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","article-title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","volume":"106","author":"Bea","year":"2005","journal-title":"Blood"},{"key":"R30-4-20210202","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"N Engl J Med"},{"key":"R31-4-20210202","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2005.02.4786","article-title":"Prognostic biomarkers in diffuse large B-cell lymphoma","volume":"24","author":"Lossos","year":"2006","journal-title":"J Clin Oncol"},{"key":"R32-4-20210202","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2005-02-0542","article-title":"Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma","volume":"106","author":"Tagawa","year":"2005","journal-title":"Blood"},{"key":"R33-4-20210202","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R34-4-20210202","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"R35-4-20210202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1008201729596","article-title":"Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients","volume":"9","author":"Vitolo","year":"1998","journal-title":"Ann Oncol"},{"key":"R36-4-20210202","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V95.6.2084","article-title":"A monoclonal antibody (MUM1p) detects expression of the MUM1\/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells","volume":"95","author":"Falini","year":"2000","journal-title":"Blood"},{"key":"R37-4-20210202","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/modpathol.3800396","article-title":"Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis","volume":"18","author":"Berglund","year":"2005","journal-title":"Mod Pathol"},{"key":"R38-4-20210202","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2002-04-1286","article-title":"Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma","volume":"101","author":"Colomo","year":"2003","journal-title":"Blood"},{"key":"R39-4-20210202","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2006.09.4490","article-title":"Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications\u2014A Study From the Lunenburg Lymphoma Biomarker Consortium","volume":"25","author":"De Jong","year":"2007","journal-title":"J Clin Oncol"},{"key":"R40-4-20210202","first-page":"1046","article-title":"Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes","volume":"11","author":"De Leon","year":"1998","journal-title":"Mod Pathol"},{"key":"R41-4-20210202","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2559.2003.01758.x","article-title":"Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance","volume":"43","author":"De Leval","year":"2003","journal-title":"Histopathology"},{"key":"R42-4-20210202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R43-4-20210202","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/path.1924","article-title":"Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma","volume":"208","author":"Muris","year":"2006","journal-title":"J Pathol"},{"key":"R44-4-20210202","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2006-09-047068","article-title":"Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy","volume":"109","author":"Nyman","year":"2007","journal-title":"Blood"},{"key":"R45-4-20210202","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/annonc\/mdm012","article-title":"Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy","volume":"18","author":"Veelken","year":"2007","journal-title":"Ann Oncol"},{"key":"R46-4-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.2007.13.0690","article-title":"LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab","volume":"26","author":"Natkunam","year":"2008","journal-title":"J Clin Oncol"},{"key":"R47-4-20210202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V90.1.244","article-title":"Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma","volume":"90","author":"Gascoyne","year":"1997","journal-title":"Blood"},{"key":"R48-4-20210202","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood.V87.1.265.265","article-title":"Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)","volume":"87","author":"Hermine","year":"1996","journal-title":"Blood"},{"key":"R49-4-20210202","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.2005.03.4264","article-title":"BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma","volume":"24","author":"Iqbal","year":"2006","journal-title":"J Clin Oncol"},{"key":"R50-4-20210202","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1200\/JCO.1996.14.7.2131","article-title":"Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study","volume":"14","author":"Kramer","year":"1996","journal-title":"J Clin Oncol"},{"key":"R51-4-20210202","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood.V92.9.3152","article-title":"Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma","volume":"92","author":"Kramer","year":"1998","journal-title":"Blood"},{"key":"R52-4-20210202","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM199708213370804","article-title":"Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma","volume":"337","author":"Ichikawa","year":"1997","journal-title":"N Engl J Med"},{"key":"R53-4-20210202","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","article-title":"Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma","volume":"90","author":"Koduru","year":"1997","journal-title":"Blood"},{"key":"R54-4-20210202","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/annonc\/mdf185","article-title":"p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas","volume":"13","author":"Leroy","year":"2002","journal-title":"Ann Oncol"},{"key":"R55-4-20210202","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V83.6.1460.1460","article-title":"Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial","volume":"83","author":"Miller","year":"1994","journal-title":"Blood"},{"key":"R56-4-20210202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ajh.10333","article-title":"Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma","volume":"73","author":"Sohn","year":"2003","journal-title":"Am J Hematol"},{"key":"R57-4-20210202","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V99.3.815","article-title":"De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients","volume":"99","author":"Yamaguchi","year":"2002","journal-title":"Blood"},{"key":"R58-4-20210202","first-page":"207","article-title":"De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct","volume":"147","author":"Matolcsy","year":"1995","journal-title":"Am J Pathol"},{"key":"R59-4-20210202","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2559.2007.02721.x","article-title":"Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients","volume":"51","author":"Amen","year":"2007","journal-title":"Histopathology"},{"key":"R60-4-20210202","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"R61-4-20210202","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF02983534","article-title":"Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma","volume":"79","author":"Ueda","year":"2004","journal-title":"Int J Hematol"},{"key":"R62-4-20210202","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1634\/theoncologist.11-4-384","article-title":"T-cell\/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management","volume":"11","author":"Abramson","year":"2006","journal-title":"Oncologist"},{"key":"R63-4-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2559.2002.01291.x","article-title":"Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features","volume":"40","author":"Achten","year":"2002","journal-title":"Histopathology"},{"key":"R64-4-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00000478-199201000-00006","article-title":"Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype","volume":"16","author":"Delabie","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R65-4-20210202","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma","volume":"102","author":"Boudova","year":"2003","journal-title":"Blood"},{"key":"R66-4-20210202","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2559.1991.tb00024.x","article-title":"Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease","volume":"19","author":"Chittal","year":"1991","journal-title":"Histopathology"},{"key":"R67-4-20210202","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1365-2559.2002.01466.x","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma","volume":"41","author":"Fraga","year":"2002","journal-title":"Histopathology"},{"key":"R68-4-20210202","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2003.06.046","article-title":"T-cell\/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis","volume":"21","author":"Bouabdallah","year":"2003","journal-title":"J Clin Oncol"},{"key":"R69-4-20210202","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood.V93.8.2679","article-title":"Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells","volume":"93","author":"Brauninger","year":"1999","journal-title":"Blood"},{"key":"R70-4-20210202","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2005-03-0897","article-title":"Gene expression and angiotropism in primary CNS lymphoma","volume":"107","author":"Rubenstein","year":"2006","journal-title":"Blood"},{"key":"R71-4-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2008-04-149005","article-title":"Primary lymphoma of the central nervous system: just DLBCL or not?","volume":"113","author":"Montesinos-Rongen","year":"2009","journal-title":"Blood"},{"key":"R72-4-20210202","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood-2003-05-1465","article-title":"Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation","volume":"103","author":"Montesinos-Rongen","year":"2004","journal-title":"Blood"},{"key":"R73-4-20210202","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0002-9440(10)65526-5","article-title":"Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment","volume":"155","author":"Montesinos-Rongen","year":"1999","journal-title":"Am J Pathol"},{"key":"R74-4-20210202","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R75-4-20210202","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/00000478-200312000-00006","article-title":"Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes","volume":"27","author":"Goodlad","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R76-4-20210202","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1200\/JCO.1998.16.6.2080","article-title":"bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related","volume":"16","author":"Geelen","year":"1998","journal-title":"J Clin Oncol"},{"key":"R77-4-20210202","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"R78-4-20210202","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"key":"R79-4-20210202","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1349-7006.2000.tb00909.x","article-title":"The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(\u2212) cases in Japanese population","volume":"91","author":"Kuze","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"R80-4-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.46.1","article-title":"Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review","volume":"46","author":"Shimoyama","year":"2006","journal-title":"J Clin Exp Hematop"},{"key":"R81-4-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R82-4-20210202","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients","volume":"13","author":"Oyama","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R83-4-20210202","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\u201cGroupe d'Etude des Lymphomes de l'Adulte\u201d) study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R84-4-20210202","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1997.15.4.1646","article-title":"Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients","volume":"15","author":"Lazzarino","year":"1997","journal-title":"J Clin Oncol"},{"key":"R85-4-20210202","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/112.2.241","article-title":"CD30 expression is common in mediastinal large B-cell lymphoma","volume":"112","author":"Higgins","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R86-4-20210202","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood.V94.10.3567.422k06_3567_3575","article-title":"The MAL gene is expressed in primary mediastinal large B-cell lymphoma","volume":"94","author":"Copie-Bergman","year":"1999","journal-title":"Blood"},{"key":"R87-4-20210202","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"key":"R88-4-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the \u2018cutaneous variant\u2019","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"key":"R89-4-20210202","first-page":"444","article-title":"Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors","volume":"1","author":"Ferry","year":"1988","journal-title":"Mod Pathol"},{"key":"R90-4-20210202","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":"Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"key":"R91-4-20210202","first-page":"826","article-title":"An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome","volume":"111","author":"Murase","year":"2000","journal-title":"Br J Haematol"},{"key":"R92-4-20210202","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00000478-200206000-00005","article-title":"Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype","volume":"26","author":"Petitjean","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R93-4-20210202","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pap.0000194627.50878.02","article-title":"Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation","volume":"12","author":"Aozasa","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"R94-4-20210202","first-page":"249","article-title":"Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases","volume":"19","author":"Iuchi","year":"1989","journal-title":"Jpn J Clin Oncol"},{"key":"R95-4-20210202","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1200\/JCO.2002.09.021","article-title":"Pyothorax-associated lymphoma: a review of 106 cases","volume":"20","author":"Nakatsuka","year":"2002","journal-title":"J Clin Oncol"},{"key":"R96-4-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/annonc\/mdl349","article-title":"Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients","volume":"18","author":"Narimatsu","year":"2007","journal-title":"Ann Oncol"},{"key":"R97-4-20210202","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00000478-199511000-00011","article-title":"Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection","volume":"19","author":"Myers","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R98-4-20210202","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(197901)43:1<360::AID-CNCR2820430151>3.0.CO;2-8","article-title":"Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases","volume":"43","author":"Katzenstein","year":"1979","journal-title":"Cancer"},{"key":"R99-4-20210202","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V87.11.4531.bloodjournal87114531","article-title":"Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b","volume":"87","author":"Wilson","year":"1996","journal-title":"Blood"},{"key":"R100-4-20210202","first-page":"233","article-title":"Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications","volume":"30","author":"Jaffe","year":"1997","journal-title":"Cancer Surv"},{"key":"R101-4-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/00313028609059478","article-title":"Lymphomatoid granulomatosis: a clinicopathologic study of 42 patients","volume":"18","author":"Koss","year":"1986","journal-title":"Pathology"},{"key":"R102-4-20210202","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00000478-200311000-00012","article-title":"A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation","volume":"27","author":"Adam","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R103-4-20210202","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.MP.0000081729.40230.1F","article-title":"ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC)","volume":"16","author":"Chikatsu","year":"2003","journal-title":"Mod Pathol"},{"key":"R104-4-20210202","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood.V89.5.1483","article-title":"A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation","volume":"89","author":"Delsol","year":"1997","journal-title":"Blood"},{"key":"R105-4-20210202","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2003-03-0786","article-title":"ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases","volume":"102","author":"Gascoyne","year":"2003","journal-title":"Blood"},{"key":"R106-4-20210202","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"R107-4-20210202","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1368-8375(01)00018-5","article-title":"Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations","volume":"38","author":"Flaitz","year":"2002","journal-title":"Oral Oncol"},{"key":"R108-4-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00000478-200401000-00003","article-title":"Oral plasmablastic lymphoma in AIDS patients are associated with human herpesvirus 8","volume":"28","author":"Cioc","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R109-4-20210202","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.pas.0000173023.02724.1f","article-title":"Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R110-4-20210202","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R111-4-20210202","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tripleo.2004.11.050","article-title":"Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature","volume":"100","author":"Scheper","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R112-4-20210202","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajh.20190","article-title":"HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum","volume":"77","author":"Schichman","year":"2004","journal-title":"Am J Hematol"},{"key":"R113-4-20210202","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000077324","article-title":"Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation","volume":"208","author":"Hausermann","year":"2004","journal-title":"Dermatology"},{"key":"R114-4-20210202","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1601-0825.2006.01336.x","article-title":"EBV detection in HIV-related oral plasmablastic lymphoma","volume":"13","author":"Ferrazzo","year":"2007","journal-title":"Oral Dis"},{"key":"R115-4-20210202","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2559.2007.02870.x","article-title":"Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders","volume":"51","author":"Borenstein","year":"2007","journal-title":"Histopathology"},{"key":"R116-4-20210202","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-2141.2002.03872.x","article-title":"Molecular histogenesis of plasmablastic lymphoma of the oral cavity","volume":"119","author":"Gaidano","year":"2002","journal-title":"Br J Haematol"},{"key":"R117-4-20210202","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"key":"R118-4-20210202","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/EQJR3D3V0CCQGP04","article-title":"Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH","volume":"128","author":"Chuang","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R119-4-20210202","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"R120-4-20210202","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/annonc\/mdi403","article-title":"Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol","volume":"16","author":"Divine","year":"2005","journal-title":"Ann Oncol"},{"key":"R121-4-20210202","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.ejca.2004.09.004","article-title":"Gender and age-related differences in Burkitt lymphoma\u2014epidemiological and clinical data from The Netherlands","volume":"40","author":"Boerma","year":"2004","journal-title":"Eur J Cancer"},{"key":"R122-4-20210202","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"key":"R123-4-20210202","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.MP.0000019577.73786.64","article-title":"The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement","volume":"15","author":"Nakamura","year":"2002","journal-title":"Mod Pathol"},{"key":"R124-4-20210202","first-page":"337","article-title":"Burkitt's lymphoma: a review of the pathology, immunology, and possible etiologic factors","volume":"6","author":"Wright","year":"1971","journal-title":"Pathol Annu"},{"key":"R125-4-20210202","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.leukres.2008.03.037","article-title":"AIDS-related Burkitt lymphoma-A heterogeneous disease?","volume":"32","author":"Danilov","year":"2008","journal-title":"Leuk Res"},{"key":"R126-4-20210202","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1200\/JCO.1998.16.12.3788","article-title":"Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group","volume":"16","author":"Davi","year":"1998","journal-title":"J Clin Oncol"},{"key":"R127-4-20210202","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ajcp\/103.5.561","article-title":"AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens","volume":"103","author":"Carbone","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"R128-4-20210202","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/labinvest.3780264","article-title":"TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma","volume":"81","author":"Said","year":"2001","journal-title":"Lab Invest"},{"key":"R129-4-20210202","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1309\/77V7U4E03V69QHRR","article-title":"TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma","volume":"124","author":"Teitell","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R130-4-20210202","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMe068075","article-title":"Burkitt's lymphoma\u2014the message from microarrays","volume":"354","author":"Harris","year":"2006","journal-title":"N Engl J Med"},{"key":"R131-4-20210202","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1182\/blood-2006-12-064865","article-title":"Gene-expression analysis identifies novel RBL2\/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors","volume":"110","author":"De Falco","year":"2007","journal-title":"Blood"},{"key":"R132-4-20210202","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","article-title":"Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas","volume":"106","author":"Bellan","year":"2005","journal-title":"Blood"},{"key":"R133-4-20210202","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jcp.56.3.188","article-title":"Burkitt's lymphoma: new insights into molecular pathogenesis","volume":"56","author":"Bellan","year":"2003","journal-title":"J Clin Pathol"},{"key":"R134-4-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1044-579X(02)00058-5","article-title":"Role of genetic and epigenetic changes in Burkitt lymphoma","volume":"12","author":"Lindstrom","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"R135-4-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":"Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis","volume":"19","author":"Kanungo","year":"2006","journal-title":"Mod Pathol"},{"key":"R136-4-20210202","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","article-title":"The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC rearrangement","volume":"92","author":"Le Gouill","year":"2007","journal-title":"Haematologica"},{"key":"R137-4-20210202","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1097\/01.pas.0000180442.87022.08","article-title":"Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior","volume":"29","author":"McClure","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R138-4-20210202","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.pas.0000168176.71405.e5","article-title":"Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma","volume":"29","author":"Haralambieva","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R139-4-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAS.0b013e3180959e09","article-title":"Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation","volume":"32","author":"Rodig","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R140-4-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.2870020211","article-title":"Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11)","volume":"2","author":"Thangavelu","year":"1990","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"R141-4-20210202","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/annonc\/9.suppl_5.S31","article-title":"Workshop report on Hodgkin's disease and related diseases (\u201cgrey zone\u201d lymphoma)","volume":"9","author":"Rudiger","year":"1998","journal-title":"Ann Oncol"},{"key":"R142-4-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ajcp\/96.1.81","article-title":"Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma","volume":"96","author":"Gonzalez","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"R143-4-20210202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2559.2005.02175.x","article-title":"Large B-cell lymphoma with Hodgkin's features","volume":"47","author":"Garcia","year":"2005","journal-title":"Histopathology"},{"key":"R144-4-20210202","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R145-4-20210202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"R146-4-20210202","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"R147-4-20210202","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000478-200103000-00003","article-title":"Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): A GELA Study","volume":"25","author":"Cazals-Hatem","year":"2001","journal-title":"Am J Surg Pathol"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00125480-200907000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T14:36:17Z","timestamp":1633617377000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00125480-200907000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":147,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0b013e3181a9d5d2","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}